Generic Name and Formulations:
 Balsalazide disodium 1.1g; tabs; contains sodium 126mg/tab.

Company:
Salix Pharmaceuticals, Inc.
e-Prescribe this drug via Surescripts 

Therapeutic Use:

Colorectal disorders

Product Resources »•Product Information
•Coupons, Samples & Vouchers
•Patient Education and Assistance

Drug News:•Giazo, a UC Treatment for Male Patients

Gastrohepatic Disorders Resource Center »

Indications for GIAZO:

Mildly-to-moderately active ulcerative colitis in male patients. Limitations of use: effectiveness in treatment of female patients was not demonstrated. Safety and effectiveness of therapy beyond 8 weeks have not been established.

Adult Dose for GIAZO:

≥18yrs: 3 tabs twice daily; max 8 weeks.

Children's Dose for GIAZO:

<18yrs: not established.

Pharmacological Class:

Aminosalicylate.

Warnings/Precautions:

Monitor for worsening symptoms of ulcerative colitis. Discontinue if acute intolerance syndrome is suspected. Known or history of renal impairment. Monitor renal function prior to initating and periodically during therapy. Hepatic impairment; consider monitoring LFTs during therapy. Elderly. Pregnancy (Cat. B). Nursing mothers.

Adverse Reactions:

Anemia, diarrhea, pharyngolaryngeal pain, UTI.

How Supplied:

Tabs—180, 500